141 related articles for article (PubMed ID: 30976663)
1. Non-adherence among women enrolled in a contraceptive vaginal ring use study in Kisumu, Kenya, 2014-2015.
McLellan-Lemal E; Gvetadze R; Desai MA; Makanga EM; Pan Y; Haaland RE; Holder AN; Mudhune V; Williams T; Samandari T
J Glob Health Rep; 2018; 2():. PubMed ID: 30976663
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.
Stifani BM; Plagianos M; Vieira CS; Merkatz RB
Contraception; 2018 May; 97(5):415-421. PubMed ID: 29269252
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
4. Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis.
Delvaux T; Jespers V; Benova L; van de Wijgert J
Front Glob Womens Health; 2021; 2():799963. PubMed ID: 34970653
[No Abstract] [Full Text] [Related]
5. Characteristics of women screened for a contraceptive intravaginal ring study in Kisumu, Kenya, 2014.
McLellan-Lemal E; Gust DA; Gvetadze R; Furtado M; Otieno FO; Desai M; Zeh C; Samandari T; Nyagol B; Makanga EM
Res J Womens Health; 2016; 3():. PubMed ID: 27441094
[TBL] [Abstract][Full Text] [Related]
6. The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.
Schurmans C; De Baetselier I; Kestelyn E; Jespers V; Delvaux T; Agaba SK; van Loen H; Menten J; van de Wijgert J; Crucitti T;
BMC Public Health; 2015 Apr; 15():348. PubMed ID: 25880636
[TBL] [Abstract][Full Text] [Related]
7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
9. Advances in contraceptive vaginal rings: what does the future hold?
Monteiro I; Guazzelli CF; Bahamondes L
Expert Opin Pharmacother; 2018 Oct; 19(15):1685-1691. PubMed ID: 30286682
[TBL] [Abstract][Full Text] [Related]
10. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Jackanicz T
Contraception; 1997 Oct; 56(4):233-9. PubMed ID: 9408704
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction.
Merkatz RB; Plagianos M; Hoskin E; Cooney M; Hewett PC; Mensch BS
Contraception; 2014 Nov; 90(5):514-21. PubMed ID: 24993487
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
13. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
Nel A; van Niekerk N; Van Baelen B; Malherbe M; Mans W; Carter A; Steytler J; van der Ryst E; Craig C; Louw C; Gwetu T; Mabude Z; Kotze P; Moraba R; Tempelman H; Gill K; Kusemererwa S; Bekker LG; Devlin B; Rosenberg Z;
Lancet HIV; 2021 Feb; 8(2):e77-e86. PubMed ID: 33539761
[TBL] [Abstract][Full Text] [Related]
14. Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
Simmons KB; Kumar N; Plagianos M; Roberts K; Hoskin E; Han L; Alami M; Creasy G; Variano B; Merkatz R
Contraception; 2018 Mar; 97(3):270-276. PubMed ID: 29097225
[TBL] [Abstract][Full Text] [Related]
15. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
Haaland RE; Holder A; Evans-Strickfaden T; Nyagol B; Makanga M; Oyaro B; Humwa F; Williams T; McLellan-Lemal E; Desai M; Huey MJ
Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
[TBL] [Abstract][Full Text] [Related]
16. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
Elkik F; Basdevant A; Jackanicz TM; Guy-Grand B; Mercier-Bodard C; Conard J; Bardin CW; Corvol P
J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360
[TBL] [Abstract][Full Text] [Related]
17. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
van der Straten A; Agot K; Ahmed K; Weinrib R; Browne EN; Manenzhe K; Owino F; Schwartz J; Minnis A;
J Int AIDS Soc; 2018 Mar; 21(3):e25094. PubMed ID: 29600595
[TBL] [Abstract][Full Text] [Related]
18. Adolescents' willingness to use the contraceptive vaginal ring.
Maheux-Lacroix S; Leboeuf M; Dufresne A; Dodin S
J Obstet Gynaecol Can; 2011 Apr; 33(4):353-360. PubMed ID: 21501540
[TBL] [Abstract][Full Text] [Related]
19. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
20. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
